LAUSANNE, Switzerland (AP) — LAUSANNE, Switzerland (AP) — AC Immune SA (ACIU) on Tuesday reported third-quarter net income of $6.4 million, after reporting a loss in the same period a year earlier.
The Lausanne, Switzerland-based company said it had net income of 6 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.
The biopharmaceutical company posted revenue of $29.4 million in the period.
The company's shares closed at $2.95. A year ago, they were trading at $2.83.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACIU at https://www.zacks.com/ap/ACIU
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.